Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

International, Multicenter, Double-blind, Randomized, Comparative Study of the Pharmacokinetics, Safety and Efficacy of RPH-075 and Keytruda® in Patients With Malignant Neoplasms

NCT06307093 is registered in ClinicalTrials.gov with R-Pharm as lead sponsor.

NCT NCT06307093
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06307093 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
International, Multicenter, Double-blind, Randomized, Comparative Study of the Pharmacokinetics, Safety and Efficacy of RPH-075 and Keytruda® in Patients With Malignant Neoplasms
Lead sponsor
R-Pharm
Phase
Phase 1
Overall status
Completed
Start date
March 1, 2023
Completion date
July 28, 2025
Enrollment
90 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck squamous cell carcinoma, skin melanoma, squamous non-small-cell lung cancer